Tactile Systems Technology Q4 2023 Earnings Report

Tactile Systems Technology EPS Results

• Actual EPS: $0.38
• Consensus EPS: $0.13
• Beat/Miss: Beat by +$0.25
• One Year Ago EPS: $0.29

Tactile Systems Technology Revenue Results

• Actual Revenue: $77.65 million
• Expected Revenue: $78.85 million
• Beat/Miss: Missed by -$1.20 million
• YoY Revenue Growth: N/A

Tactile Systems Technology Announcement Details

• Quarter: Q4 2023
• Date: 2/20/2024
• Time: Before Market Opens

Tactile Systems Technology (NASDAQ:TCMD), a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.